USANA Health Sciences (NYSE:USNA) Director Gilbert Fuller Sells 1,058 Shares of Stock

USANA Health Sciences, Inc. (NYSE:USNA) Director Gilbert Fuller sold 1,058 shares of USANA Health Sciences stock in a transaction on Friday, March 20th. The stock was sold at an average price of $17.00, for a total value of $17,986.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.

USANA Health Sciences Price Performance

Shares of NYSE:USNA opened at $16.88 on Friday. The company has a market cap of $311.61 million, a P/E ratio of 30.70, a PEG ratio of 0.71 and a beta of 0.64. USANA Health Sciences, Inc. has a 1 year low of $16.72 and a 1 year high of $38.32. The stock’s fifty day moving average price is $20.29 and its 200-day moving average price is $21.88.

USANA Health Sciences (NYSE:USNA) last released its quarterly earnings data on Tuesday, February 17th. The company reported $0.60 EPS for the quarter, topping the consensus estimate of $0.41 by $0.19. USANA Health Sciences had a return on equity of 6.75% and a net margin of 1.16%.The company had revenue of $226.20 million during the quarter, compared to the consensus estimate of $225.96 million. On average, sell-side analysts anticipate that USANA Health Sciences, Inc. will post 2.45 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on USNA. Zacks Research raised shares of USANA Health Sciences from a “strong sell” rating to a “hold” rating in a report on Monday, February 16th. Wall Street Zen raised shares of USANA Health Sciences from a “hold” rating to a “buy” rating in a research report on Saturday, February 21st. Finally, Weiss Ratings reiterated a “sell (d)” rating on shares of USANA Health Sciences in a research note on Monday, December 29th. One equities research analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, USANA Health Sciences has a consensus rating of “Reduce”.

Institutional Trading of USANA Health Sciences

Several large investors have recently added to or reduced their stakes in USNA. National Bank of Canada FI raised its position in USANA Health Sciences by 166.6% in the third quarter. National Bank of Canada FI now owns 1,922 shares of the company’s stock worth $53,000 after acquiring an additional 1,201 shares during the period. Tower Research Capital LLC TRC increased its stake in shares of USANA Health Sciences by 382.5% in the 2nd quarter. Tower Research Capital LLC TRC now owns 2,398 shares of the company’s stock worth $73,000 after purchasing an additional 1,901 shares in the last quarter. Parallel Advisors LLC raised its holdings in USANA Health Sciences by 1,354.3% in the 4th quarter. Parallel Advisors LLC now owns 3,854 shares of the company’s stock worth $76,000 after purchasing an additional 3,589 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank raised its holdings in USANA Health Sciences by 52.9% in the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,834 shares of the company’s stock worth $106,000 after purchasing an additional 1,327 shares during the period. Finally, iSAM Funds UK Ltd purchased a new position in USANA Health Sciences during the third quarter valued at $120,000. 54.25% of the stock is currently owned by institutional investors.

About USANA Health Sciences

USANA Health Sciences, Inc is a Utah‐based company that develops, manufactures and distributes nutritional supplements and personal care products through a network of independent distributors. Founded in 1992 by Dr. Myron Wentz, the company’s portfolio includes vitamins, minerals, dietary supplements, weight‐management products and skin‐care formulations. USANA’s products are formulated in its own laboratories to meet pharmaceutical‐grade standards, and the company has invested heavily in research and development and quality control to support its offerings.

Operating primarily through a direct selling model, USANA serves markets in North America, Asia Pacific, Europe and Latin America.